T-wave oversensing in patients with Brugada syndrome: true bipolar versus integrated bipolar implantable cardioverter defibrillator leads: multicenter retrospective study.

Circ Arrhythm Electrophysiol

From the Hospital Clínico Universitario de Santiago de Compostela (CHUS), Santiago de Compostela, Spain (M.R.-M., L.M.-S., J.R.G.-J.); Department of Cardiology, Vrije Universiteit Brussel (VUB), Brussels, Belgium (C.d.A., G.-B.C., P.B.); Bordeaux University Hospital, LIRYC Institute/INSERM 1045, Bordeaux, France (F.S., M.H.); Hospital Clínic Universitario de Barcelona, Institut du Thorax, Barcelona, Spain (E.A., J.B.); CHU de Nantes, Nantes, France (V.P., J.-B.G.); Instituto de Cardiología y Cirugía Cardiovascular, La Habana, Cuba (J.C.-H.); CHU de Toulouse, Toulouse, France (P.M., A.R.); St. Bartholomew's Hospital, London, United Kingdom (P.L., R.S.); Clinica Universidad de Navarra, Pamplona, Spain (I.G.-B.); and Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, Japan (K.F.-K., T.K.).

Published: August 2015

Background: It is thought that dedicated bipolar are more susceptible to T-wave oversensing when compared with integrated bipolar leads. This could be of extreme importance in patients with Brugada syndrome (BrS) because T-wave oversensing in this population is more frequent when compared with other implantable cardioverter defibrillator (ICD) recipients without BrS. We aimed to compare the incidence of T-wave oversensing in patients with BrS according to the type of lead (integrated bipolar versus true/dedicated bipolar).

Methods And Results: All patients diagnosed with BrS with an ICD implant in 10 tertiary hospitals between 1993 and 2013 were included in the study. A total of 480 patients were included (mean age, 45.6±14 years). During a mean follow-up of 74.9±51.7 months (median, 69; range, 2-236), 28 patients had T-wave oversensing (5.8%), leading to inappropriate shock in 18 (3.8%). All these events occurred in patients with true bipolar ICD leads (P=0.01) and in 2 patients it was solved instantaneously by changing the configuration from a dedicated to an integrated bipolar sensing configuration. In the stepwise multivariate models, only integrated bipolar ICD leads (hazard ratio, 0.34; 95% confidence interval, 0.171-0.675; P=0.002) was independent predictor of non-T-wave oversensing.

Conclusions: T-wave oversensing is a potential reason of inappropriate shocks in patients with BrS receiving ICDs. In the vast majority it can be solved by reprogramming. However, in some patients it still requires invasive intervention. Importantly, incidence is significantly lower using an integrated bipolar lead system when compared with a dedicated bipolar lead system and hence the latter should be routinely used in BrS cases.

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCEP.115.002871DOI Listing

Publication Analysis

Top Keywords

t-wave oversensing
24
integrated bipolar
24
patients
10
bipolar
10
oversensing patients
8
patients brugada
8
brugada syndrome
8
true bipolar
8
bipolar versus
8
implantable cardioverter
8

Similar Publications

Introduction: The novel Confirm Rx™ implantable cardiac monitor (ICM) with SharpSense™ technology incorporates a new P-wave discriminator designed to improve AF detection. This study aimed to evaluate the diagnostic performance of the Confirm Rx™ ICM in detecting AF episodes of varying durations.

Methods: We conducted a multicenter retrospective analysis of consecutive patients implanted with a Confirm Rx™ ICM (v1.

View Article and Find Full Text PDF

Insertable cardiac monitor (ICM), used for long-term heart rhythm monitoring, often experiences diagnostic challenges such as T-wave oversensing, leading to false positives. This case report presents a novel approach to rectifying T-wave oversensing in ICM implantations. In this case, we are sharing a 38-year-old female with recurrent syncopal episodes who underwent ICM implantation (LUX-Dx™, ICM-Boston Scientific, Marlborough, United States).

View Article and Find Full Text PDF

Using artificial intelligence and deep learning to optimise the selection of adult congenital heart disease patients in S-ICD screening.

Indian Pacing Electrophysiol J

June 2024

Cardiac Rhythm Management Research Department, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Introduction: The risk of complications associated with transvenous ICDs make the subcutaneous implantable cardiac defibrillator (S-ICD) a valuable alternative in patients with adult congenital heart disease (ACHD). However, higher S-ICD ineligibility and higher inappropriate shock rates-mostly caused by T wave oversensing (TWO)- are observed in this population. We report a novel application of deep learning methods to screen patients for S-ICD eligibility over a longer period than conventional screening.

View Article and Find Full Text PDF

Aims: Subcutaneous implantable cardioverter-defibrillators (S-ICDs) offer potentially distinct advantages over transvenous defibrillator systems. Recent randomized trials showed significantly lower lead failure rates than transvenous ICD. Still, S-ICDs remain associated with the risk of inappropriate shocks (IAS).

View Article and Find Full Text PDF

A 66-year-old female with end-stage renal disease and heart failure with reduced ejection fraction, status post implantable cardioverter defibrillator (ICD) presented to the emergency department with dizziness and fatigue. An electrocardiogram showed sinus rhythm, complete atrioventricular block, and ventricular paced rhythm at 30 beats per minute (bpm). Device interrogation revealed a programmed VVI mode with a lower rate limit of 40 bpm and evidence of T wave oversensing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!